Olainfarm AS represents values of transparency, innovation, and excellence in the pharmaceutical industry. The company is committed to delivering high-quality and affordable medication to improve the health and well-being of individuals worldwide. Olainfarm AS embraces a corporate philosophy centered around integrity, social responsibility, and sustainable growth. By adhering to strict ethical standards, the company consistently strives for customer satisfaction and long-term partnerships. With a focus on research and development, Olainfarm AS aims to continuously introduce new and advanced healthcare solutions that meet the evolving needs of patients.

Olainfarm AS is primarily present in Latvia, where it is headquartered. As a leading pharmaceutical company, Olainfarm also has a strong presence in other Baltic countries, including Estonia and Lithuania. The company focuses on developing, manufacturing, and distributing pharmaceutical products throughout these regions. With its commitment to high-quality healthcare solutions, Olainfarm AS continues to expand its presence and serve customers in various markets within the Baltic region.

Olainfarm AS, a renowned pharmaceutical company, has achieved several significant milestones. Over the years, the company has successfully expanded its product portfolio, strengthened its market position, and secured international partnerships. Notably, Olainfarm AS has experienced considerable sales growth, reaching new heights in revenue and profitability. The introduction of innovative drugs, robust research and development, and compliance with international quality standards have also contributed to the company's success. Furthermore, Olainfarm AS has successfully entered new markets, establishing a global presence and enhancing its brand recognition. These achievements highlight Olainfarm AS's commitment to excellence and its continuous efforts to provide high-quality pharmaceutical products to a diverse range of customers worldwide.

Olainfarm AS is a renowned pharmaceutical company with a rich history and background. Founded in 1972, Olainfarm AS is headquartered in Olaine, Latvia. It has grown to become one of the largest pharmaceutical manufacturers in the Baltic States, specializing in the development, production, and sale of generic and innovative medications. With a wide range of products spanning various therapeutic areas, Olainfarm AS has a strong focus on research and development, ensuring high-quality and effective pharmaceutical solutions. The company has forged numerous partnerships and collaborations, enabling it to reach global markets and establish a strong presence internationally. Olainfarm AS's commitment to innovation and excellence has contributed to its consistent growth and success in the pharmaceutical industry.

The main competitors of Olainfarm AS in the market include pharmaceutical companies such as Grindeks, Tallinn Pharmaceutical Plant, and Pharmasystems. These companies operate in the same industry as Olainfarm AS and compete for market share in the production and sale of pharmaceutical products. However, Olainfarm AS has established a strong presence in the market with its diverse portfolio of high-quality medications and strategic partnerships, allowing it to maintain a competitive edge against its rivals. Additionally, Olainfarm AS continues to focus on research and development, innovative solutions, and expanding its market reach to stay ahead of the competition.

Olainfarm AS is primarily active in the pharmaceutical and chemical industries. As one of the leading pharmaceutical companies in the Baltic States, Olainfarm AS specializes in the development, production, and distribution of generic pharmaceuticals and active pharmaceutical ingredients (APIs). With a diverse portfolio of over 60 products, the company caters to various therapeutic categories, including cardiology, neurology, gastroenterology, and more. Olainfarm AS's dedication to quality and innovation has enabled its presence in both domestic and international markets, making it a prominent player in the pharmaceutical industry.

The business model of Olainfarm AS revolves around the pharmaceutical industry and the development, manufacturing, and sales of pharmaceutical products. Olainfarm AS focuses on producing high-quality generic medicines, as well as over-the-counter drugs and active pharmaceutical ingredients (APIs). With a strong emphasis on research and development, Olainfarm AS continuously works on expanding its product portfolio and improving the production processes to ensure customer satisfaction and meet the market demand. The company's goal is to provide affordable healthcare solutions while maintaining a sustainable and profitable business model. Olainfarm AS strives to establish itself as a global leader in the pharmaceutical industry through innovation, quality, and strong partnerships.

KGV kan i øjeblikket ikke beregnes for Olainfarm AS.

KUV kan i øjeblikket ikke beregnes for Olainfarm AS.

AlleAktien Kvalitetsscore for Olainfarm AS er 2/10.

Omsætningen kan i øjeblikket ikke beregnes for Olainfarm AS.

Overskuddet kan i øjeblikket ikke beregnes for Olainfarm AS.

Olainfarm AS is a leading pharmaceutical company based in Latvia. The company was founded in 1972 and has become one of the largest pharmaceutical companies in the region over the years. Olainfarm AS operates at all levels of the value chain, from research and development to the production and marketing of globally available products. The business model of Olainfarm AS consists of various divisions focusing on the production and marketing of: - Generics - OTC products - Pharmaceutical active ingredients - Animal medicines Generics Olainfarm AS is known for manufacturing generics that are well-known worldwide. Generics are replicas of trademarked drugs that contain the same active ingredient as the original medication. The production of generics is more cost-effective than producing original lines, allowing customers to purchase the desired medication at a lower price. Olainfarm AS works closely with regulatory authorities to ensure that all generics comply with legal requirements. OTC products Olainfarm AS also offers over-the-counter (OTC) products that are sold without a prescription and can be used for mild to moderate illnesses. Olainfarm AS produces a variety of OTC products for various indications, including pain relief, anti-inflammation, cough, and cold. The company operates a strong distribution network for OTC products, reaching customers in multiple countries. Pharmaceutical active ingredients Olainfarm AS also manufactures pharmaceutical active ingredients for use in various medications. These active ingredients are the active components in drugs that treat diseases or alleviate symptoms. Olainfarm AS has extensive experience in the production and marketing of pharmaceutical active ingredients. The company works closely with other pharmaceutical companies to use these active ingredients in other medications, and also sources active ingredients from other manufacturers to produce its own medical products. Animal medicines Olainfarm AS also manufactures animal medicines for various conditions. These medicines are used in the treatment of pets and farm animals and include antibiotics, antifungals, and insecticides. Olainfarm AS has a specialized distribution network for animal medicines, reaching animal owners and veterinarians in different countries. Overall, the business model of Olainfarm AS is focused on manufacturing and selling a wide range of pharmaceutical products that are available worldwide. The company has extensive experience in the production of generics, OTC products, pharmaceutical active ingredients, and animal medicines, and works closely with other pharmaceutical companies to distribute these products. It operates a strong distribution network in multiple countries and collaborates closely with regulatory authorities to ensure that all products comply with legal requirements.

Olainfarm AS udbetaler et udbytte på 0 EUR fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Olainfarm AS, eller selskabet udbetaler ikke udbytte.

ISIN'en for Olainfarm AS er LV0000100501.

WKN for Olainfarm AS er 907441.

Tickeren for Olainfarm AS er OLF1R.RG.

I løbet af de sidste 12 måneder betalte Olainfarm AS en dividende på 0,32 EUR . Dette svarer til et dividendeudbytte på omkring 3,46 %. For de kommende 12 måneder vil Olainfarm AS sandsynligvis betale en dividende på 0,32 EUR.

Udbytteafkastet for Olainfarm AS er i øjeblikket 3,46 %.

Olainfarm AS betaler kvartalsvis udbytte. Dette uddeles i månederne november, august, november, august.

Olainfarm AS betalte udbytte hvert år i løbet af de sidste 5 år.

For de kommende 12 måneder forventes der dividender på 0,32 EUR. Dette svarer til et dividendeafkast på 3,46 %.

Olainfarm AS bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Olainfarm AS fra den 12.7.2021 på 0,17 EUR, skulle du have haft aktien i din portefølje før ex-datoen den 8.7.2021.

Udbetalingen af det sidste udbytte blev foretaget den 12.7.2021.

I løbet af 2024 udbetalte Olainfarm AS 0,1 EUR i form af dividender.

Udbytterne fra Olainfarm AS udbetales i EUR.